Nanoparticles and microparticles for skin drug delivery

作者：Prow Tar W; Grice Jeffrey E; Lin Lynlee L; Faye Rokhaya; Butler Margaret; Becker Wolfgang; Wurm Elisabeth M T; Yoong Corinne; Robertson Thomas A; Soyer H Peter; Roberts Michael S^*

来源：Advanced Drug Delivery Reviews, 2011, 63(6): 470-491.

DOI：10.1016/j.addr.2011.01.012

• Nanoparticle
• Drug delivery
• Topical
• Skin
• Percutaneous penetration
• Transdermal delivery

Skin is a widely used route of delivery for local and systemic drugs and is potentially a route for their delivery as nanoparticles. The skin provides a natural physical barrier against particle penetration, but there are opportunities to deliver therapeutic nanoparticles, especially in diseased skin and to the openings of hair follicles. Whilst nanoparticle drug delivery has been touted as an enabling technology, its potential in treating local skin and systemic diseases has yet to be realised. Most drug delivery particle technologies are based on lipid carriers, i.e. solid lipid nanoparticles and nanoemulsions of around 300 nm in diameter, which are now considered microparticles. Metal nanoparticles are now recognized for seemingly small drug-like characteristics, i.e. antimicrobial activity and skin cancer prevention. We present our unpublished clinical data on nanoparticle penetration and previously published reports that support the hypothesis that nanoparticles >10 nm in diameter are unlikely to penetrate through the stratum corneum into viable human skin but will accumulate in the hair follicle openings, especially after massage. However, significant uptake does occur after damage and in certain diseased skin. Current chemistry limits both atom by atom construction of complex particulates and delineating their molecular interactions within biological systems. In this review we discuss the skin as a nanoparticle barrier, recent work in the field of nanoparticle drug delivery to the skin, and future directions currently being explored.

• 出版日期2011-5-30